Blog
SKAN will miss sales and profit expectations for 2025 – order intake and backlog are developing very positively and laying a strong foundation for 2026
SKAN will miss sales and profit expectations for 2025 – order intake and backlog are developing very positively and laying a strong foundation for 2026
Private Equity Holding AG: Half Year-Report as of September 30, 2025
Private Equity Holding AG: Half Year-Report as of September 30, 2025
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL TRIAL OF BV100 in CHInA
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL TRIAL OF BV100 in CHInA
EQS-News: Branicks Group AG: Steadily on track, structures simplified
EQS-News: Branicks Group AG: Steadily on track, structures simplified
EQS-News: 9-month results 2025: Basler AG confirms strong growth in sales and earnings
EQS-News: 9-month results 2025: Basler AG confirms strong growth in sales and earnings
R&S Group refines mid-term guidance and structure: growth investments more accurately reflected in an EBITDA margin range
R&S Group refines mid-term guidance and structure: growth investments more accurately reflected in an EBITDA margin range
EQS-Adhoc: Zalando SE: Zalando Launches Share Buy-back for Share-based Remuneration Programs
EQS-Adhoc: Zalando SE: Zalando Launches Share Buy-back for Share-based Remuneration Programs
Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Fuller, Smith & Turner PLC: Director / PDMR Shareholding
EQS-News: Successful Eurobond Issuance: Vonovia places Bonds with Total Volume of EUR 2.25 billion
EQS-News: Successful Eurobond Issuance: Vonovia places Bonds with Total Volume of EUR 2.25 billion
EQS-News: SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
EQS-News: SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
EQS-News: Successful nine-month performance: freenet confirms guidance – IPTV as key driver of EBITDA growth
EQS-News: Successful nine-month performance: freenet confirms guidance – IPTV as key driver of EBITDA growth
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO
Funding Circle Holdings plc: POS-Transaction in Own Shares
Funding Circle Holdings plc: POS-Transaction in Own Shares
FIGEAC AÉRO: H1 2025/26 REVENUE €215.3 MILLION, IMPLYING 9.6% ORGANIC GROWTH 18th CONSECUTIVE QUARTER OF GROWTH IN LINE WITH THE FULL-YEAR TARGET
FIGEAC AÉRO: H1 2025/26 REVENUE €215.3 MILLION, IMPLYING 9.6% ORGANIC GROWTH 18th CONSECUTIVE QUARTER OF GROWTH IN LINE WITH THE FULL-YEAR TARGET
BILENDI: 2025 revenue as of 30 September: €64.5 million, up +42.9%
BILENDI: 2025 revenue as of 30 September: €64.5 million, up +42.9%
EQS-Adhoc: Change in Indirect Ownership Structure of LM PAY S.A.
EQS-Adhoc: Change in Indirect Ownership Structure of LM PAY S.A.
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: JTC plc
Form 8.3 - The Vanguard Group, Inc.: JTC plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc
Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc


